Trial intelligence / Profile preview

Zolpidem effect on performance at high altitude

NCT02778659Completed

Sponsor
EXALT
Start
May 2016
Primary completion
Oct 2017
Countries
1
01

Overview

Randomised, double-blind trial of zolpidem sublingual tablet in Insomnia (4 arms), sponsored by EXALT. Primary endpoint: Simon cognitive test. Started May 2016; status: completed.

02

Drugs

zolpidem sublingual tablet
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT02778659.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02778659.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call